Joerg Alte
Corporate Officer/Principal chez FIDEsprit AG
Postes actifs de Joerg Alte
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FIDEsprit AG | Corporate Officer/Principal | 01/09/2007 | - |
Historique de carrière de Joerg Alte
Anciens postes connus de Joerg Alte
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | President | 01/11/1998 | 01/04/2000 |
| PROTEO, INC. | Directeur/Membre du Conseil | 01/01/2000 | - |
Statistiques
Internationale
| Etats-Unis | 2 |
| Allemagne | 2 |
| Suisse | 2 |
Opérationnelle
| Director/Board Member | 1 |
| President | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Proteo, Inc.
 Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
| FIDEsprit AG |
- Bourse
- Insiders
- Joerg Alte
- Expérience
